Pediatrics CME

Credits: 0.50 CME
Medical Learning Institute, Inc.
Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement
June 10, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Meeting Therapeutic Challenges in Pediatric ALL: Expert Perspectives on the Use of Asparaginase Compounds
May 19, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
May 18, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
April 14, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
March 30, 2021
Credits: 0.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease: Examining the Current State of the Science
March 26, 2021
Credits: 0.50 CME
Penn State College of Medicine
A Visual Guide to B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape
March 26, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
RCC MasterClass and Clinical Consult: Remodeling the Treatment Algorithm With Novel Immune and Targeted Therapies
March 4, 2021
Credits: 0.50 ABO / CME / MOC
Medical Learning Institute, Inc.
A Quick Look at Recent Evidence for Improving Outcomes in Patients With Diabetic Retinopathy Using Anti-VEGF Therapy
February 25, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expanding the Benefits of Immuno-Oncology to More Patients With Solid Tumors Through Novel Rational Targets and Combinations
February 24, 2021
Credits: 0.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care
February 15, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Taking an Individualized Approach to Neovascular Age-Related Macular Degeneration: Examining the Evidence to Improve Patient Outcomes
February 12, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches
February 9, 2021
Credits: 1.75 CME / MOC
Medical Learning Institute, Inc.
Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies
February 8, 2021
Credits: 1.00 CME / NCPD / CPE
Medical Learning Institute, Inc.
Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
February 1, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants: When Is It Appropriate to Implement Reversal Strategies in Patients With GI Bleeding?
January 26, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
January 26, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
January 22, 2021
Credits: 0.25 CME
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
December 31, 2020

Pages